An improved HPLC method overcoming Beer's law deviations arising from supramolecular interactions in tolfenamic acid and cyclodextrins complexes

被引:28
作者
Rozou, S
Antoniadou-Vyza, E [1 ]
机构
[1] Univ Athens, Sch Pharm, Dept Pharmaceut Chem, GR-15771 Athens, Greece
[2] ELPEN SA Pharmaceut Co, R&D Dept, Attica, Greece
关键词
tolfenamic acid; methyl and hydroxypropyl-beta-cyclodextrin complexes; reversed-phase chromatography; method validation;
D O I
10.1016/S0731-7085(98)00227-1
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Inclusion complexes of tolfenamic acid (TA), a non-steroidal anti-inflammatory drug, with methyl-beta cyclodextrin and hydroxypropyl-beta cyclodextrin were prepared and characterised. Spectrophotometric, chromatographic (RP-HPLC) and H-1 NMR studies of the complexes were conducted. It was observed that cyclodextrins influence TA's molar absorptivity leading to Beer's law deviation. Consequently, the accuracy problem arose, urged for the application of specific chromatographic conditions for the determination of TA in the presence of CDs. A new HPLC method was developed and validated. TA was analysed on a C18 column 5 mu m (150 x 4.6 mm), using a column thermostat regulated at 30 degrees C. The mobile phase consisted of methanol-phosphate buffer solution (pH 3.2; 0.07 M) (90:10 v/v) and the flow rate was set at 2.0 mi min(-1). The detector was operated at 286 nm. TA was successfully determined, overcoming the problems arising from the presence of cyclodextrins. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:899 / 905
页数:7
相关论文
共 20 条
[1]  
ADAMOVICH JA, 1990, CHROMATOGRAPHIC SCI, V24, P15
[2]   CHARACTERIZATION, DISSOLUTION AND BIOAVAILABILITY IN RATS OF IBUPROFEN - BETA-CYCLODEXTRIN COMPLEX SYSTEM [J].
CHOW, DD ;
KARARA, AH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 28 (2-3) :95-101
[3]   INCLUSION COMPOUNDS .19. FORMATION OF INCLUSION COMPOUNDS OF ALPHA-CYCLODEXTRIN IN AQUEOUS SOLUTIONS . THERMODYNAMICS AND KINETICS [J].
CRAMER, F ;
SAENGER, W ;
SPATZ, HC .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1967, 89 (01) :14-&
[4]  
DJEDAINI F, 1991, NEW TRENDS CYCLODEXT, P215
[6]  
HIRAYAMA F, 1987, CYCLODEXTRINS THEIR, P00133
[7]  
Huber L., 1998, LC GC EUR, V11, P96
[8]   Pharmaceutical applications of cyclodextrins .1. Drug solubilization and stabilization [J].
Loftsson, T ;
Brewster, ME .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (10) :1017-1025
[9]   EFFECT OF MAGNESIUM-HYDROXIDE ON THE ABSORPTION OF TOLFENAMIC AND MEFENAMIC ACIDS [J].
NEUVONEN, PJ ;
KIVISTO, KT .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (05) :495-501
[10]   DETERMINATION OF TOLFENAMIC ACID IN HUMAN PLASMA BY HPLM [J].
NIOPAS, I ;
GEORGARAKIS, M .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1995, 18 (13) :2675-2682